Skip to content
Screener

Pacific Biosciences of California PACB Business Segments — Intangible Amortization

Similar metrics at other companies

BellRing Brands logo
BRBRReportable Segment — Intangible Amortization
$4.2M0.0%
Powell Industries logo
POWLReportable Segment — Intangible Amortization
$223K
TaskUs logo
TASKReportable Segment — Intangible Amortization
$5M+0.1%
Citizens Community Bancorp logo
CZWIReportable Segment — Intangible Amortization
$113K-36.9%
Claritev Corporation logo
CTEVReportable Segment — Intangible Amortization
$85.91M-0.1%
Insmed logo
INSMReportable Segment — Intangible Amortization
$2.08M+64.8%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$368.06M-5.6%
Enterprise value$367.25M-4.8%
P/S2.3×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Settlement charges15,400
Gain on disposal of assets(45,796)
Change in fair value of contingent consideration(18,700)
Amortization of acquired intangible assets8338331,666362,875
Operating loss(44,610)(44,853)(52,967)(473,787)
Other (expense) income, net(73)2,9581935,515
Loss before income taxes(44,683)(41,895)(52,774)(468,272)
Income tax provision (benefit)5835242(267)

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's business segments — intangible amortization?
Pacific Biosciences of California (PACB) reported business segments — intangible amortization of $833K in Q2 2026.
How has Pacific Biosciences of California's business segments — intangible amortization changed year-over-year?
Pacific Biosciences of California's business segments — intangible amortization decreased by 0.0% year-over-year, from $833K to $833K.
What does business segments — intangible amortization mean?
This is the systematic allocation of the cost of acquired intangible assets, such as patents, technology, and customer relationships, over their estimated useful lives. It is a non-cash expense that reflects the consumption of the value of acquired intellectual property.

Ask your AI about Pacific Biosciences of California's business segments — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude